Glofitamab in Relapsed/Refractory Mantle Cell Lymphoma: Results From a Phase I/II Study.
Phillips TJ, Carlo-Stella C, Morschhauser F, Bachy E, Crump M, Trněný M, Bartlett NL, Zaucha J, Wrobel T, Offner F, Humphrey K, Relf J, Filézac de L'Etang A, Carlile DJ, Byrne B, Qayum N, Lundberg L, Dickinson M.
Phillips TJ, et al. Among authors: byrne b.
J Clin Oncol. 2024 Oct 4:JCO2302470. doi: 10.1200/JCO.23.02470. Online ahead of print.
J Clin Oncol. 2024.
PMID: 39365960